Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Ming Zheng, MD
CONTACT
Yundai Chen, MD
CONTACT
Lead
Shanghai MicroPort Medical (Group) Co., Ltd.
This clinical trial will enroll 375 subjects and assign to groups in a 1:1:1 ratio (base on Intravascular Ultrasound \[IVUS\]-guided treatment group : Optical Coherence Tomography \[OCT\]-guided treatment group : Quantitative Coronary Angiography \[QCA\]-guided treatment group) who have moderate-severe calcified lesions in de novo native coronary artery with ≥2.50 mm to ≤4.00 mm in diameter (visual measurement) from a maximum of 25 study sites in China. After the stent is implanted satisfactorily, OCT examinations will be performed on the subjects of these three groups to observe stent expansion after implantation. At 13 months after procedure, all subjects will receive QCA examination. OCT sub-group study: The initial 66 ongoing subjects from the three treatment groups (IVUS-guided treatment group : OCT-guided treatment group : QCA-guided treatment group) who provided informed consent and successfully randomized will receive OCT examinations at three months follow up after baseline procedure.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
